RAD51D has subsequently been investigated in an additional series of 175 breast and ovarian cancer families, with an additional mutation being identified among the 51 families with at least two ovarian cancers (and among the 75 probands affected by ovarian cancer) [4]. The gene discussed is RAD51D; the disease is ovarian cancer.